Publications by Researcher: Chalk, AM

YearTitleAuthor(s)
2013 Modeling distinct osteosarcoma subtypes in vivo using Cre:lox and lineage-restricted transgenic shRNA
Mutsaers, AJ Ng, AJM Baker, EK Russell, MR Chalk, AM Wall, M Liddicoat, BJJ Ho, PWM Slavin, JL Goradia, A Martin, TJ Purton, LE Dickins, RA Walkley, CR
2014 The SKI proto-oncogene enhances the in vivo repopulation of hematopoietic stem cells and causes myeloproliferative disease
Singbrant, S Wall, M Moody, J Karlsson, G Chalk, AM Liddicoat, B Russell, MR Walkley, CR Karlsson, S
2014 The Rothmund-Thomson syndrome helicase RECQL4 is essential for hematopoiesis
Smeets, MF DeLuca, E Wall, M Quach, JM Chalk, AM Deans, AJ Heierhorst, J Purton, LE Izon, DJ Walkley, CR
2015 RNA EDITING RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself
Liddicoat, BJ Piskol, R Chalk, AM Ramaswami, G Higuchi, M Hartner, JC Li, JB Seeburg, PH Walkley, CR
2015 Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo.
Ho, PW Goradia, A Russell, MR Chalk, AM Milley, KM Baker, EK Danks, JA Slavin, JL Walia, M Crimeen-Irwin, B Dickins, RA Martin, TJ Walkley, CR
2015 Wnt inhibitory factor 1 (WIF1) is a marker of osteoblastic differentiation stage and is not silenced by DNA methylation in osteosarcoma
Baker, EK Taylor, S Gupte, A Chalk, AM Bhattacharya, S Green, AC Martin, TJ Strbenac, D Robinson, MD Purton, LE Walkley, CR
2015 Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo
Ho, PWM Goradia, A Russell, MR Chalk, AM Milley, KM Baker, EK Danks, JA Slavin, JL Walia, M Crimeen-Irwin, B Dickins, RA Martin, TJ Walkley, CR
2015 BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells
Baker, EK Taylor, S Gupte, A Sharp, PP Walia, M Walsh, NC Zannettino, ACW Chalk, AM Burns, CJ Walkley, CR
2015 Systematic Screening Identifies Dual PI3K and mTOR Inhibition as a Conserved Therapeutic Vulnerability in Osteosarcoma
Gupte, A Baker, EK Wan, SS Stewart, E Loh, A Shelat, AA Gould, CM Chalk, AM Taylor, S Lackovic, K Karlstrom, A Mutsaers, AJ Desai, J Madhamshettiwar, PB Zannettino, ACW Burns, C Huang, DCS Dyer, MA Simpson, KJ Walkley, CR
2015 Systematic Screening Identifies Dual PI3K and mTOR Inhibition as a Conserved Therapeutic Vulnerability in Osteosarcoma
Gupte, A Baker, EK Wan, SS Stewart, E Loh, A Shelat, AA Gould, CM Chalk, AM Taylor, S Lackovic, K Karlstrom, A Mutsaers, AJ Desai, J Madhamshettiwar, PB Zannettino, AC Burns, C Huang, DC Dyer, MA Simpson, KJ Walkley, CR
2016 Adenosine-to-inosine RNA editing by ADAR1 is essential for normal murine erythropoiesis
Purton, LE Li, JB Piskol, R Wall, M Lu, J Hartner, JC Sankaran, VG Orkin, SH Liddicoat, BJ Kingsley, PD Palis, J Chalk, AM Seeburg, PH Ramaswami, G Walkley, CR
2016 ADAR1, inosine and the immune sensing system: distinguishing self from non-self
Liddicoat, BJ Chalk, AM Walkley, CR